These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A role for endorphins in the pathophysiology of spinal cord injury. Faden AI; Holaday JW Adv Biochem Psychopharmacol; 1981; 28():435-46. PubMed ID: 7211553 [TBL] [Abstract][Full Text] [Related]
3. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone. Holaday JW Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678 [No Abstract] [Full Text] [Related]
4. Naloxone after spinal cord injury. Faden AI Neurosurgery; 1987 Sep; 21(3):429-31. PubMed ID: 3670591 [No Abstract] [Full Text] [Related]
7. Endorphins in traumatic spinal injury. Pathophysiologic studies and clinical implications. Faden AI; Holaday JW Mod Probl Pharmacopsychiatry; 1981; 17():158-74. PubMed ID: 6276721 [No Abstract] [Full Text] [Related]
8. Possibilities to evaluate and diminish the effects of the trauma in spinal cord lesions. An experimental study in the rat. Winkler T Scand J Rehabil Med Suppl; 1994; 30():81-2. PubMed ID: 7886432 [No Abstract] [Full Text] [Related]
9. Secondary injury mechanisms in acute spinal cord injury. Young W J Emerg Med; 1993; 11 Suppl 1():13-22. PubMed ID: 8445198 [TBL] [Abstract][Full Text] [Related]
10. Contrasting actions of naloxone in experimental spinal cord trauma and cerebral ischemia: a review. Hamilton AJ; Black PM; Carr DB Neurosurgery; 1985 Nov; 17(5):845-9. PubMed ID: 2999639 [TBL] [Abstract][Full Text] [Related]
11. Effects of progesterone on experimental spinal cord injury. Fee DB; Swartz KR; Joy KM; Roberts KN; Scheff NN; Scheff SW Brain Res; 2007 Mar; 1137(1):146-52. PubMed ID: 17204255 [TBL] [Abstract][Full Text] [Related]
12. The effect of long-term high-dose naloxone infusion in experimental blunt spinal cord injury. Baskin DS; Simpson RK; Browning JL; Dudley AW; Rothenberg F; Bogue L J Spinal Disord; 1993 Feb; 6(1):38-43. PubMed ID: 8439715 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of erythropoietin in preclinical models of shock and organ failure. Thiemermann C Crit Care; 2007; 11(3):132. PubMed ID: 17543134 [TBL] [Abstract][Full Text] [Related]
14. Naloxone: new therapeutic roles. Milne B; Jhamandas K Can Anaesth Soc J; 1984 May; 31(3 Pt 1):272-8. PubMed ID: 6372956 [No Abstract] [Full Text] [Related]
15. Abnormal spontaneous potentials in distal muscles in animal models of spinal cord injury. Burns AS; Lemay MA; Tessler A Muscle Nerve; 2005 Jan; 31(1):46-51. PubMed ID: 15508125 [TBL] [Abstract][Full Text] [Related]
16. Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats. Colak A; Kelten B; Sağmanligil A; Akdemir O; Karaoğlan A; Sahan E; Celik O; Barut S J Clin Neurosci; 2008 Jun; 15(6):665-71. PubMed ID: 18343118 [TBL] [Abstract][Full Text] [Related]
17. Naloxone: a study of its use in shock. Halpern J J Emerg Nurs; 1984; 10(4):222-5. PubMed ID: 6381847 [No Abstract] [Full Text] [Related]
18. Brain protection by methylprednisolone in rats with spinal cord injury. Chang CM; Lee MH; Wang TC; Weng HH; Chung CY; Yang JT Neuroreport; 2009 Jul; 20(10):968-72. PubMed ID: 19525878 [TBL] [Abstract][Full Text] [Related]
19. The effects of pentoxifylline on spinal cord blood flow after experimental spinal cord injury. Thompson MK; Tuma RF; Young WF J Assoc Acad Minor Phys; 1999; 10(1):23-6. PubMed ID: 10826005 [TBL] [Abstract][Full Text] [Related]